Thomas A. Ryan was mentioned in the December 23 issue of the Am Law Litigation Daily in an article regarding Judge Philip Gutierrez's dismissal of a class action brought against Amgen, DaVita and Fresenius Medical Care North America. The plaintiffs, seven health benefit plans, claimed that the defendants promoted off-label uses of several Amgen drugs. Judge Gutierrez agreed with the defendants' argument that the case was an impermissible attempt to bring a private cause of action under the Food, Drug and Cosmetics Act. Only the FDA has the authority to bring such actions. Mr. Ryan represents Davita in the case.